Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?

Fingolimod 0.5-mg once-daily is an approved therapy for patients with relapsing–remitting multiple sclerosis (MS). Several pivotal and real-world studies have demonstrated that fingolimod is associated with the development of macular edema (ME). Herein, we present a case of a diabetic MS patient who...

Descripción completa

Detalles Bibliográficos
Autores principales: Pul, Refik, Osmanovic, Alma, Schmalstieg, Holger, Pielen, Amelie, Pars, Kaweh, Schwenkenbecher, Philipp, Sühs, Kurt Wolfram, Yildiz, Özlem, Frank, Benedikt, Stangel, Martin, Skripuletz, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187906/
https://www.ncbi.nlm.nih.gov/pubmed/27983657
http://dx.doi.org/10.3390/ijms17122106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187906/
https://www.ncbi.nlm.nih.gov/pubmed/27983657
http://dx.doi.org/10.3390/ijms17122106

Ejemplares similares